Vaccines and febrile seizures (Q38132266)

29 August 2017

title

Vaccines and febrile seizures (English)

1 reference

29 August 2017

2

1 reference

29 August 2017

1

Nicola Principi

1 reference

29 August 2017

publication date

1 August 2013

1 reference

Expert Review of Vaccines

29 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 August 2017

volume

12

1 reference

29 August 2017

issue

8

1 reference

29 August 2017

page(s)

885-892

1 reference

Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Genetic and environmental factors in febrile seizures: a Danish population-based twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Increased number of febrile seizures in children born very preterm: relation of neonatal, febrile and epileptic seizures and neurological dysfunction to seizure outcome at 16 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Fetal growth retardation and risk of febrile seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Register-based studies on febrile seizures in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Seizure susceptibility due to antihistamines in febrile seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Predictors of epilepsy in children who have experienced febrile seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Factors prognostic of unprovoked seizures after febrile convulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Role of viral infections in the etiology of febrile seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Fever after immunization: current concepts and improved future scientific understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Vaccination, seizures and 'vaccine damage'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Parents' fear regarding fever and febrile seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

A placebo-controlled trial of a pertussis-toxoid vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Lack of association between acellular pertussis vaccine and seizures in early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Measles-containing vaccines and febrile seizures in children age 4 to 6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Adverse events associated with 2010 CSL and other inactivated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Possible contribution of interferon-alpha to febrile seizures in influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Application of pharmacogenomics to vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Anthrax vaccine: short-term safety experience in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: data from a randomized, Phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.814781

10.1586/14760584.2013.814781

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference